由Tally Health开发的CheekAge测试估计通过DNA甲基化、优于血液测试的死亡率风险。 CheekAge test, developed by Tally Health, estimates mortality risk through DNA methylation, outperforming blood-based tests.

Tally Health开发的新测试名为CheekAge, 通过分析DNA甲基化的非侵入性脸颊网估计死亡风险。 A new test called CheekAge, developed by Tally Health, estimates mortality risk through a non-invasive cheek swab that analyzes DNA methylation. 这一方法大大优于早先的血液测试。 This method significantly outperforms earlier blood-based tests. 一项涉及1 513名老年人的研究发现,较高的CheekAge与死亡率风险增加有关。 A study involving 1,513 older adults found that higher CheekAge correlates with increased mortality risk. 研究人员旨在探索特定基因与老龄化之间的联系,从而有可能帮助改变生活方式和提供医疗处方,以改善健康结果。 Researchers aim to explore links between specific genes and aging, potentially aiding in lifestyle changes and medical prescriptions to improve health outcomes.